Public funding often plays a key role in research and development (R & D) of new medicines. But innovative drugs are often not affordable for people in poor countries. How can access to publicly-funded innovations be secured for as many people as possible? How can we improve access to medicine for people in developing countries? One possible solution for this challenge is "Equitable Licensing". Equitable licenses, examples of which have been developed by legal experts and universities in the USA, are specific licenses for the technology transfer between public institutions and the pharmaceutical industry.
This brochure presents background information about challenges in the drug supply in poor countries. Numerous case studies show the US experience with new licensing models and highlight possible approaches for the specific German setting.
Download Brochure [PDF/ 1,3MB]